Expert says Moderna-Merck-partnered melanoma vaccine a 'big deal' for cancer treatment
few seconds ago
Expert says Moderna-Merck-partnered melanoma vaccine a 'big deal' for cancer treatment
Early results from Moderna’s personalised mRNA cancer vaccine have been described as a “big deal” by U.S. cancer specialist Dr. Ryan Sullivan. Developed with Merck and used alongside Keytruda, the therapy could reduce melanoma recurrence risk and pave the way for personalised treatments for other cancers.